CRANBURY, N.J.--(BUSINESS WIRE)--The American Journal of Managed Care® (AJMC®), the leading multimedia peer-reviewed journal dedicated to issues in managed care, presents its most recent “Peer Exchange” panel discussion, “The Challenges and Treatment of Sickle Cell Disease.”
“Although there are some effective treatments that can minimize SCD symptoms and prolong life, our panel of experts, led by Dr. Neil Minkoff, will explore current treatment regimens and discuss other emerging therapies for the treatment of SCD,” said Michael J. Hennessy Jr., president of MJH Life Sciences™, parent company of AJMC®.
This AJMC® “Peer Exchange” panel will feature four distinguished experts:
- Neil Minkoff, M.D., former senior medical director, Harvard Pilgrim Health Care and founder of Fountainhead HealthCare, as moderator.
- Maria Lopes, M.D., former chief medical officer, Magellan Rx Management.
- John Stancil, R.Ph., pharmacy director, Division of Health Benefits, North Carolina Department of Health and Human Services.
- Ahmar U. Zaidi, M.D., pediatric hematologist-oncologist, Comprehensive Sickle Cell Center, Children’s Hospital of Michigan.
The “Peer Exchange” will begin with an in-depth overview of SCD that defines the difference between sickle cell trait and SCD, as well as the genetic predisposition of SCD. Current treatment options for patients with SCD will be discussed, including the role of hydroxyurea in the pathophysiology of SCD, the mechanism of action of L-glutamine in treating SCD, blood transfusion therapy and hematopoietic stem cell transplantation. Challenges in the management of SCD will also be shared from a multitude of perspectives. Finally, a review of the emerging agents will be presented.
For more information and to view the video series, click here.
About The American Journal of Managed Care®
The American Journal of Managed Care® (AJMC®) is a multimedia peer-reviewed, MEDLINE-indexed journal that keeps industry leaders on the forefront of health policy by sharing digital research relevant to industry decision-makers. Other brands in the AJMC® family include The American Journal of Accountable Care®, Evidence-Based Oncology™ and Evidence-Based Diabetes Management™. These comprehensive multimedia brands bring together stakeholder views from payers, providers, policymakers and other industry leaders in managed care. AJMC® is a brand of MJH Life Sciences™, the largest privately held, independent, full-service medical media company in the U.S. dedicated to delivering trusted health care news across multiple channels.